|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|
| Revenue | ||||
| Costs and operating expenses: | ||||
| Cost of revenue (excluding depreciation and amortization) | ||||
| Operations and support | ||||
| General and administrative | ||||
| Research and development | ||||
| Sales and marketing | ||||
| Impairment losses | ||||
| Integration costs | ||||
| Restructuring and other charges | ||||
| Total costs and operating expenses | ||||
| Loss from operations | ||||
| Interest expense, net | ||||
| Change in fair value of share-settled redemption feature and gain on conversion of convertible notes | ||||
| Change in fair value of SPAC Warrants | ||||
| Change in fair value of Earn Out Liability | ||||
| Lease adjustment (gains), net | ||||
| Loss on preferred stock issuance | ||||
| Change in fair value of forward contract | ||||
| Other expense (income), net | ||||
| Total non-operating expense, net | ||||
| Loss before income taxes | ||||
| Benefit for income taxes | ||||
| Net loss | ||||
| Change in foreign currency translation adjustment | ||||
| Comprehensive loss | ||||
| Basic net loss per common share (in dollars per share) | ||||
| Total basic net loss per common share (in dollars per share) | ||||
| Diluted net loss per common share (in dollars per share) | ||||
| Total diluted net loss per common share (in dollars per share) | ||||
Loading...